HomeAI · summaries
Storia in 3 fonti
Lilly, Resilience commit $750M to boost US diabetes, obesity med production
Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies embark on a $750 million investment to increase production of Lilly’s KwikPen injectable device for its diabetes | Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies plan to invest $750 million to increase production of Lilly’s KwikPen injectable device for its diabetes and obesity medicines Mounjaro and Zepbound.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Lilly, Resilience commit $750M to boost US diabetes, obesity med production
Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies embark on a $750 million investment to increase production of Lilly’s KwikPen injectable device…
- ·
endpoints.news
Gerresheimer divests two businesses worth €1.5B; Resilience, Lilly boost injectable pen capacity
Gerresheimer sells Centor and PPP unit to Apax Funds for €1.5B; Resilience and Lilly invest $750M in Ohio manufacturing; Teva books $70M European impairment charge.
